DJIA 15,660.18 -254.56 -1.60%
NASDAQ 4,266.84 -16.76 -0.39%
S&P 500 1,829.08 -22.78 -1.23%
market minute promo

Revance Therapeutics, Inc (NASDAQ: RVNC)

16.79 -0.04 (-0.24%)

Quote as of


company name or ticker

Recent Quotes

RVNC $16.79 -0.24%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $16.56
Previous Close $16.83
Daily Range $16.01 - $17.44
52-Week Range $14.10 - $42.41
Market Cap $471.2M
P/E Ratio -6.21
Dividend (Yield) $0.00 (0.0%)
Volume 304,121
Average Daily Volume 425,682
Current FY EPS -$3.32

Sector

Industry

Revance Therapeutics, Inc (RVNC) Description

Revance Therapeutics, Inc Website: http://www.revance.com/

News & Commentary Rss Feed

Why Revance Therapeutics Is Vaulting Higher Today

Interim results from a mid stage trial could mean that Revance Therapeutics has a better-than-Botox drug in development.

The Zacks Analyst Blog Highlights: AbbVie, Amgen, Ligand Pharmaceuticals, Revance Therapeutics and E

The Zacks Analyst Blog Highlights: AbbVie, Amgen, Ligand Pharmaceuticals, Revance Therapeutics and Exelixis

Revance Therapeutics (RVNC) Highlighted As Weak On High Volume

Revance Therapeutics (RVNC) Stock: Weak On High Volume Today

Watch These Four Stocks On Christmas Eve Morning

Revance Therapeutics (RVNC) Strong On High Relative Volume Today

Bottomline With Revance

Revance Therapeutics (RVNC) Weak On High Volume Today

How Revance Is Misleading Investors About RT002

Can The Uptrend Continue for Revance (RVNC)?

Can The Uptrend Continue for Revance (RVNC)?

Commit To Buy Revance Therapeutics At $25, Earn 18.9% Annualized Using Options

See More RVNC News...